Filing Details
- Accession Number:
- 0001237899-10-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-20 18:31:39
- Reporting Period:
- 2010-12-16
- Filing Date:
- 2010-12-20
- Accepted Time:
- 2010-12-20 18:31:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp F&A, Cfo, Treas & Asst Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-16 | 16,250 | $13.00 | 59,984 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-16 | 6,642 | $31.80 | 53,342 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2010-12-16 | 4,440 | $31.80 | 48,902 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2010-12-17 | 5,168 | $32.15 | 43,734 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-12-16 | 16,250 | $0.00 | 16,250 | $13.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,058 | 2013-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,136 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 5,168 shares of Company stock on December 17, 2010 at prices ranging from $31.81 to $32.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2010 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.
Billionaire Hedge Funds
